Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: A cohort study

Thrombosis Research

Volumn 132, Issue 1, 2013, Pages 51-55

  Le Moigne, Emmanuelle ^a,b   Delluc, Aurélien ^a,b   Tromeur, Cécile ^a,b   Nowak, Emmanuel ^a,b   Mottier, Dominique ^a,b   Lacut, Karine ^a,b   Le Gal, Gregoire ^a,b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

Combined; Oral contraceptives; Recurrence; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; CYPROTERONE; DESOGESTREL; DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORGESTIMATE; GESTODENE; LEVONORGESTREL; NORETHISTERONE; NORGESTIMATE;

ADULT; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

COMBINED; ORAL CONTRACEPTIVES; RECURRENCE; VENOUS THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; COHORT STUDIES; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; INCIDENCE; RECURRENCE; RISK FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84881312570     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.05.028     Document Type: Article

References (19)

1. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S. Goldhaber Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 2012 e419s e494s
2. S. McRae, H. Tran, S. Schulman, J. Ginsberg, and C. Kearon Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis Lancet 368 9533 2006 371 378 (Pubitemid 44108120)
3. J. Douketis, A. Tosetto, M. Marcucci, T. Baglin, B. Cosmi, and M. Cushman Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis BMJ 342 2011 d813
4. G. Agnelli, C. Becattini, and P. Prandoni Recurrent venous thromboembolism in men and women N Engl J Med 351 19 2004 2015 2018 [author reply - 8] (Pubitemid 39447146)
5. P.O. Hansson, J. Sorbo, and H. Eriksson Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors Arch Intern Med 160 6 2000 769 774 (Pubitemid 30165237)
6. O. Lidegaard, E. LOkkegaard, A.L. Svendsen, and C. Agger Hormonal contraception and risk of venous thromboembolism: national follow-up study BMJ 339 2009 b2890
7. M. Cushman, L.H. Kuller, R. Prentice, R.J. Rodabough, B.M. Psaty, and R.S. Stafford Estrogen plus progestin and risk of venous thrombosis JAMA 292 13 2004 1573 1580 (Pubitemid 39314963)
8. M. Cushman, R.J. Glynn, S.Z. Goldhaber, S. Moll, K.A. Bauer, and S. Deitcher Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial J Thromb Haemost 4 10 2006 2199 2203 (Pubitemid 44400298)
9. G. Le Gal, M.J. Kovacs, M. Carrier, K. Do, S.R. Kahn, and P.S. Wells Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study Thromb Haemost 104 3 2010 498 503
10. I. Pabinger, H. Grafenhofer, A. Kaider, P.A. Kyrle, P. Quehenberger, and C. Mannhalter Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis J Thromb Haemost 3 5 2005 949 954 (Pubitemid 41632825)
11. W.M. Lijfering, N.J. Veeger, S. Middeldorp, K. Hamulyak, M.H. Prins, and H.R. Buller Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives Blood 113 21 2009 5314 5322
12. S.C. Christiansen, W.M. Lijfering, F.M. Helmerhorst, F.R. Rosendaal, and S.C. Cannegieter Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event J Thromb Haemost 8 10 2010 2159 2168
13. P.A. Kyrle, E. Minar, C. Bialonczyk, M. Hirschl, A. Weltermann, and S. Eichinger The risk of recurrent venous thromboembolism in men and women N Engl J Med 350 25 2004 2558 2563
14. T. Baglin, R. Luddington, K. Brown, and C. Baglin High risk of recurrent venous thromboembolism in men J Thromb Haemost 2 12 2004 2152 2155 (Pubitemid 40185775)
15. A. Tosetto, A. Iorio, M. Marcucci, T. Baglin, M. Cushman, and S. Eichinger Predicting disease recurrence in patients with previous unprovoked venous thromboembolism:a proposed prediction score (DASH) J Thromb Haemost 10 6 2012 1019 1025
16. N. Bajos, H. Leridon, H. Goulard, P. Oustry, and N. Job-Spira Contraception: from accessibility to efficiency Hum Reprod 18 5 2003 994 999 (Pubitemid 36592040)
17. M.A. Rodger, S.R. Kahn, P.S. Wells, D.A. Anderson, I. Chagnon, and G. Le Gal Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy CMAJ 179 5 2008 417 426
18. J.P. Vandenbroucke, K. Koster, T. Briet, P.H. Reitsma, R.M. Bertina, and F.R. Rosendaal Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 344 8935 1994 1453 1457 (Pubitemid 24351698)
19. E.F. Van Vlijmen, N.J. Veeger, S. Middeldorp, K. Hamulyak, M.H. Prins, and H.R. Buller Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception Blood 118 8 2011 2055 2061